Senior insider sale
LINEAGE CELL THERAPEUTICS, INC. — senior position signals high conviction
$97.5K
80K shares
What this filing means
BAILEY DON M plans to sell 80K shares of LINEAGE CELL THERAPEUTICS, INC. valued at approximately $97.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2025ACC: 0001950047-25-006959
Director
Since Mar 2019
80K
Shares to sell
$97.5K
Approx. market value
80K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
9/10/2025
80KTotal acquired80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/10/2025 | Stock Option Exercise Cash | 80K | — |
| Total | 80K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
80K
Market value
$97.5K
9/10/2025
Total
Units
80K
Value
$97.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/10/2025 | 80K | $97.5K | NYSE | Planned |
| Total | 80K | $97.5K | ||